CXCL11 Correlates with Immune Infiltration and Impacts Patient Immunotherapy Efficacy: A Pan-Cancer Analysis

BACKGROUND: Immunotherapy has achieved great success in cancer. Nevertheless, many patients cannot benefit from immune checkpoint blockade therapy because of the scantiness of CD8+ T cell infiltration in the tumor microenvironment (TME). CXCL11 is known as a regulator that influences T-cell infiltra...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yang, Han, Shukun, Wu, Baokang, Zhong, Chongli, Shi, Yu, Lv, Chao, Fu, Lei, Zhang, Yizhou, Lang, Qi, Liang, Zhiyun, Yu, Yang, Tian, Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9355700/
https://www.ncbi.nlm.nih.gov/pubmed/35935945
http://dx.doi.org/10.3389/fimmu.2022.951247

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9355700/
https://www.ncbi.nlm.nih.gov/pubmed/35935945
http://dx.doi.org/10.3389/fimmu.2022.951247

Ejemplares similares